Ghadeer K. Dawwas

1.0k total citations · 1 hit paper
35 papers, 626 citations indexed

About

Ghadeer K. Dawwas is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine and Epidemiology. According to data from OpenAlex, Ghadeer K. Dawwas has authored 35 papers receiving a total of 626 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Cardiology and Cardiovascular Medicine, 11 papers in Internal Medicine and 7 papers in Epidemiology. Recurrent topics in Ghadeer K. Dawwas's work include Atrial Fibrillation Management and Outcomes (11 papers), Venous Thromboembolism Diagnosis and Management (11 papers) and Diabetes Treatment and Management (6 papers). Ghadeer K. Dawwas is often cited by papers focused on Atrial Fibrillation Management and Outcomes (11 papers), Venous Thromboembolism Diagnosis and Management (11 papers) and Diabetes Treatment and Management (6 papers). Ghadeer K. Dawwas collaborates with scholars based in United States and Canada. Ghadeer K. Dawwas's co-authors include Haesuk Park, James D. Lewis, Steven M. Smith, Charles E. Leonard, Eric Dietrich, Colleen Brensinger, Adam Cuker, Joshua D. Brown, Mindie H. Nguyen and Qufei Wu and has published in prestigious journals such as Annals of Internal Medicine, Gastroenterology and Diabetes Care.

In The Last Decade

Ghadeer K. Dawwas

33 papers receiving 619 citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Incidence, Prevalence, and Racial and Ethnic Distribution of Inflammatory Bowel Disease in the United States

2023 152 citations James D. Lewis, Lauren E. Parlett et al. Gastroenterology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ghadeer K. Dawwas United States	14	193	179	155	125	120	35	626
Ephraim Rimon Israel	9	166 0.9×	115 0.6×	69 0.4×	58 0.5×	69 0.6×	12	764
Moshe Vardi Israel	14	143 0.7×	167 0.9×	41 0.3×	98 0.8×	189 1.6×	34	811
Mohammed Danjuma Qatar	13	79 0.4×	76 0.4×	51 0.3×	57 0.5×	102 0.8×	64	561
Thomas A. Mavrakanas Canada	17	580 3.0×	131 0.7×	32 0.2×	253 2.0×	170 1.4×	77	1.0k
Samiha Sarwat United States	14	163 0.8×	200 1.1×	58 0.4×	22 0.2×	149 1.2×	26	692
Pei-Wen Chao Taiwan	12	175 0.9×	268 1.5×	21 0.1×	35 0.3×	106 0.9×	22	664
Christoph Pechlaner Austria	15	140 0.7×	137 0.8×	21 0.1×	56 0.4×	67 0.6×	35	649
O.A. O’Corragain United States	13	163 0.8×	113 0.6×	16 0.1×	35 0.3×	181 1.5×	26	660
Janice D. Nunnelee United States	10	272 1.4×	57 0.3×	45 0.3×	224 1.8×	198 1.6×	43	780
Ragheb Assaly United States	15	138 0.7×	138 0.8×	15 0.1×	27 0.2×	213 1.8×	79	776

Countries citing papers authored by Ghadeer K. Dawwas

Since Specialization

Citations

This map shows the geographic impact of Ghadeer K. Dawwas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ghadeer K. Dawwas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ghadeer K. Dawwas more than expected).

Fields of papers citing papers by Ghadeer K. Dawwas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ghadeer K. Dawwas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ghadeer K. Dawwas. The network helps show where Ghadeer K. Dawwas may publish in the future.

Co-authorship network of co-authors of Ghadeer K. Dawwas

This figure shows the co-authorship network connecting the top 25 collaborators of Ghadeer K. Dawwas. A scholar is included among the top collaborators of Ghadeer K. Dawwas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ghadeer K. Dawwas. Ghadeer K. Dawwas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dawwas, Ghadeer K., Adam Cuker, & James D. Lewis. (2025). Bleeding and thrombotic outcomes with oral anticoagulants in patients with inflammatory bowel disease and venous thromboembolism. Blood Advances. 10(5). 1819–1827.

Lewis, James D., et al.. (2024). The Clinical Course of Bowel Urgency Severity Among Patients with Inflammatory Bowel Disease—A Real-World Study. Drugs - Real World Outcomes. 11(3). 403–412. 3 indexed citations

Dawwas, Ghadeer K., Alexandra Weiss, Brad D. Constant, et al.. (2023). Development and Validation of Claims-Based Definitions to Identify Incident and Prevalent Inflammatory Bowel Disease in Administrative Healthcare Databases. Inflammatory Bowel Diseases. 29(12). 1993–1996. 11 indexed citations

Lewis, James D., Lauren E. Parlett, Colleen Brensinger, et al.. (2023). Incidence, Prevalence, and Racial and Ethnic Distribution of Inflammatory Bowel Disease in the United States. Gastroenterology. 165(5). 1197–1205.e2. 152 indexed citations breakdown →

Miano, Todd A., Lei Wang, Charles E. Leonard, et al.. (2022). Identifying Clinically Relevant Drug–Drug Interactions With Methadone and Buprenorphine: A Translational Approach to Signal Detection. Clinical Pharmacology & Therapeutics. 112(5). 1120–1129. 16 indexed citations

Dawwas, Ghadeer K., James Flory, Sean Hennessy, Charles E. Leonard, & James D. Lewis. (2022). Comparative Safety of Sodium–Glucose Cotransporter 2 Inhibitors Versus Dipeptidyl Peptidase 4 Inhibitors and Sulfonylureas on the Risk of Diabetic Ketoacidosis. Diabetes Care. 45(4). 919–927. 14 indexed citations

Dawwas, Ghadeer K., Adam Cuker, Aaron Rothstein, & Sean Hennessy. (2022). Trends in post-discharge prophylactic anticoagulant use among stroke patients in the United States between 2006 and 2019. Journal of Stroke and Cerebrovascular Diseases. 31(10). 106700–106700. 1 indexed citations

Flory, James, et al.. (2021). Compared to commercially insured patients, Medicare advantage patients adopt newer diabetes drugs more slowly and adhere to them less. Endocrinology Diabetes & Metabolism. 4(3). e00245–e00245. 5 indexed citations

Dawwas, Ghadeer K., Sean Hennessy, Colleen Brensinger, et al.. (2021). Comparative Safety of Dipeptidyl Peptidase‐4 Inhibitors and Sudden Cardiac Arrest and Ventricular Arrhythmia: Population‐Based Cohort Studies. Clinical Pharmacology & Therapeutics. 111(1). 227–242. 2 indexed citations

10.

Leonard, Charles E., Colleen Brensinger, Emily K. Acton, et al.. (2021). Population‐Based Signals of Antidepressant Drug Interactions Associated With Unintentional Traumatic Injury. Clinical Pharmacology & Therapeutics. 110(2). 409–423. 7 indexed citations

11.

Dawwas, Ghadeer K., et al.. (2021). Prevalence and Factors Associated With Fecal Urgency Among Patients With Ulcerative Colitis and Crohn’s Disease in the Study of a Prospective Adult Research Cohort With Inflammatory Bowel Disease. Crohn s & Colitis 360. 3(3). otab046–otab046. 28 indexed citations

12.

Dawwas, Ghadeer K., Charles E. Leonard, James D. Lewis, & Adam Cuker. (2021). Risk for Recurrent Venous Thromboembolism and Bleeding With Apixaban Compared With Rivaroxaban: An Analysis of Real-World Data. Annals of Internal Medicine. 175(1). 20–28. 42 indexed citations

13.

Dawwas, Ghadeer K., Eric Dietrich, Adam Cuker, et al.. (2021). Effectiveness and Safety of Direct Oral Anticoagulants Versus Warfarin in Patients With Valvular Atrial Fibrillation. Annals of Internal Medicine. 174(7). 910–919. 23 indexed citations

14.

Dawwas, Ghadeer K., Charles E. Leonard, Scott Martin Vouri, et al.. (2020). Twelve‐year trends in pharmacologic treatment of type 2 diabetes among patients with heart failure in the United States. Diabetes Obesity and Metabolism. 22(4). 705–710. 3 indexed citations

15.

Dawwas, Ghadeer K., Eric Dietrich, Steven M. Smith, Kyle Davis, & Haesuk Park. (2020). Comparative Effectiveness and Safety of Direct-acting Oral Anticoagulants and Warfarin in Patients with Venous Thromboembolism and Active Cancer: An Observational Analysis. Clinical Therapeutics. 42(9). e161–e176. 4 indexed citations

16.

Dawwas, Ghadeer K., Colleen Brensinger, Ravy K. Vajravelu, et al.. (2020). Long-term Outcomes Following Multiply Recurrent Clostridioides difficile Infection and Fecal Microbiota Transplantation. Clinical Gastroenterology and Hepatology. 20(4). 806–816.e6. 17 indexed citations

17.

Leonard, Charles E., Colleen Brensinger, Ghadeer K. Dawwas, et al.. (2020). The risk of sudden cardiac arrest and ventricular arrhythmia with rosiglitazone versus pioglitazone: real-world evidence on thiazolidinedione safety. Cardiovascular Diabetology. 19(1). 25–25. 18 indexed citations

18.

Leonard, Charles E., Colleen Brensinger, John R. Horn, et al.. (2020). Screening to identify signals of opioid drug interactions leading to unintentional traumatic injury. Biomedicine & Pharmacotherapy. 130. 110531–110531. 23 indexed citations

19.

Dawwas, Ghadeer K., Steven M. Smith, & Haesuk Park. (2018). Cardiovascular outcomes of sodium glucose cotransporter‐2 inhibitors in patients with type 2 diabetes. Diabetes Obesity and Metabolism. 21(1). 28–36. 55 indexed citations

20.

Dawwas, Ghadeer K., Steven M. Smith, & Haesuk Park. (2018). Risk of heart failure hospitalization among users of dipeptidyl peptidase-4 inhibitors compared to glucagon-like peptide-1 receptor agonists. Cardiovascular Diabetology. 17(1). 102–102. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact